COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Market Cap

<< Previous

Bullboard Posts

Next >>

Comment by Hopeforthebeston Aug 31, 2024 10:59am

69 Views

Post# 36203949

RE:RE:Market Cap

proph said - "We don't know exactly what the company has but the company has attracted Ronnie Miller "

Was that the same NoShowRonnie who was quietly forced out under the guise of early retirement by his previous company and has now shown that like gagnon no person/company/financial institute want to be part of the scheme? Just asking for a friend.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in